|
|
||||||||
microbiology, Vol 145, 211-220, Copyright © 1999 by Society for General Microbiology
ARTICLES |
FR Brennan, TD Jones, LB Gilleland, T Bellaby, F Xu, PC North, A Thompson, J Staczek, T Lin, JE Johnson, WD Hamilton and HE Gilleland Jr
Axis Genetics plc, Babraham, Cambridge, UK.
A synthetic peptide (peptide 10) representing a surface-exposed, linear B cell epitope from outer-membrane (OM) protein F of Pseudomonas aeruginosa was shown previously to afford protection in mice from P. aeruginosa infection. This peptide was expressed in tandem with the protein F peptide 18 on each of the two coat proteins of cowpea mosaic virus (CPMV). The chimaeric virus particles (CVPs) expressing the peptides on the S (small) coat protein (CPMV-PAE4) and L (large) coat protein (CPMV-PAE5) were used to immunize mice. Following subcutaneous immunization in Freund's and QuilA adjuvants, CPMV-PAE4 induced antibodies predominantly against peptide 18, whereas CPMV-PAE5 produced antibodies exclusively against peptide 10, indicating that the site of peptide expression on CPMV influences its immune recognition. The anti- peptide antibodies elicited by CPMV-PAE5 were predominantly of the IgG2a isotype, indicating a highly polarized TH1-type response. The peptide-specific IgG2a strongly recognized the whole F protein, but more importantly, recognized protein F in all seven Fisher-Devlin immunotypes of P. aeruginosa. Furthermore, the peptide-specific IgG2a in CVP/QS-21 adjuvant-immunized mice was shown to bind complement and to augment phagocytosis of P. aeruginosa by human neutrophils in vitro. The ability of CPMV-PAE5 to induce P. aeruginosa-specific opsonic IgG2a gives it potential for further development as a protective vaccine against P. aeruginosa.
This article has been cited by other articles:
![]() |
K. J. Koudelka, C. S. Rae, M. J. Gonzalez, and M. Manchester Interaction between a 54-Kilodalton Mammalian Cell Surface Protein and Cowpea Mosaic Virus J. Virol., February 15, 2007; 81(4): 1632 - 1640. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Palmer, J. L. Brogdon, S. L. Constant, and P. Tattersall A Nonproliferating Parvovirus Vaccine Vector Elicits Sustained, Protective Humoral Immunity following a Single Intravenous or Intranasal Inoculation J. Virol., February 1, 2004; 78(3): 1101 - 1108. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Price, D. R. Galloway, N. R. Baker, L. B. Gilleland, J. Staczek, and H. E. Gilleland Jr. Protection against Pseudomonas aeruginosa Chronic Lung Infection in Mice by Genetic Immunization against Outer Membrane Protein F (OprF) of P. aeruginosa Infect. Immun., May 1, 2001; 69(5): 3510 - 3515. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |